Michele Malaguarnera

Papers

Total Citations

180

H-Index

About

Michele Malaguarnera is a leading figure in hepatology, with a research focus that spans the clinical management of benign liver tumors and the metabolic underpinnings of liver disease. His most cited work, a 2014 review on hepatic hemangiomas, has garnered 180 citations and remains a cornerstone for clinicians, clarifying the shifting indications for treatment of these common benign tumors, which account for 73% of all benign liver lesions. Beyond this landmark review, Malaguarnera has made significant contributions to understanding the role of insulin-like growth factors and oxidative stress in hepatocellular carcinoma and chronic liver disease. His research often bridges the gap between molecular mechanisms and practical patient care, exploring how metabolic syndrome and nutritional interventions influence liver pathology. With a career marked by over a hundred publications, his work is widely cited for providing clear, evidence-based guidelines that have directly impacted surgical decision-making and conservative management strategies for hepatic lesions. Malaguarnera’s scholarship is essential reading for any student or researcher seeking to understand the modern, nuanced approach to benign liver tumors and the metabolic factors driving liver disease progression.